Delphinus Medical Technologies, LLC develops, commercializes, sells, and services the breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presence of benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. The company was founded in 2009 and is based in Detroit, Michigan.
|Size (employees)||56 (est)+4%|
Delphinus Medical Technologies total Funding
Delphinus Medical Technologies latest funding size
Time since last funding
|3 years ago|
Delphinus Medical Technologies investors
|Arboretum Ventures, North Coast Technology Investors, Waycross Ventures, Beringea, Venture Investors, Hopen Life Science Ventures|